- |||||||||| linezolid suspension intradiscal (PP353) / Persica Pharma
Enrollment closed, Phase classification: Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain (clinicaltrials.gov) - Dec 1, 2023
P1/2, N=43, Active, not recruiting,
Intradiscal administration of 3?mL of PP353 is well-tolerated and based on the pharmacokinetics following a single injection, a two-dose regimen of PP353 (150?mg linezolid) on Day 1 and Day 5? Recruiting --> Active, not recruiting | Phase classification: P1b --> P1/2
- |||||||||| linezolid suspension intradiscal (PP353) / Persica Pharma
Trial completion date, Trial primary completion date: Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain (clinicaltrials.gov) - Apr 26, 2023
P1b, N=43, Recruiting,
Recruiting --> Active, not recruiting | Phase classification: P1b --> P1/2 Trial completion date: Jul 2023 --> Oct 2024 | Trial primary completion date: Jul 2023 --> Oct 2024
- |||||||||| linezolid suspension intradiscal (PP353) / Persica Pharma
Trial completion date, Trial primary completion date: Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain (clinicaltrials.gov) - Mar 18, 2022
P1b, N=43, Recruiting,
Trial completion date: Jul 2023 --> Oct 2024 | Trial primary completion date: Jul 2023 --> Oct 2024 Trial completion date: Feb 2023 --> Jul 2023 | Trial primary completion date: Feb 2023 --> Jul 2023
- |||||||||| linezolid suspension intradiscal (PP353) / Persica Pharma
Trial completion date, Trial primary completion date: Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain (clinicaltrials.gov) - Nov 1, 2021
P1b, N=43, Recruiting,
Trial completion date: Feb 2023 --> Jul 2023 | Trial primary completion date: Feb 2023 --> Jul 2023 Trial completion date: May 2022 --> Feb 2023 | Trial primary completion date: May 2022 --> Feb 2023
- |||||||||| linezolid suspension intradiscal (PP353) / Persica Pharma
Trial completion date, Trial primary completion date: Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain (clinicaltrials.gov) - Sep 11, 2020
P1b, N=40, Recruiting,
Trial completion date: May 2022 --> Feb 2023 | Trial primary completion date: May 2022 --> Feb 2023 Trial completion date: Sep 2021 --> May 2022 | Trial primary completion date: Sep 2021 --> May 2022
|
